Psoriatic Arthritis

Top Story

Big Data: What Every Rheumatologist Should Know

Big Data: What Every Rheumatologist Should Know
Healio Rheumatology, July 2017

With each passing year, big data has taken on a larger role in medicine and more specifically, in rheumatology.

“Here is the thing about big data, it is not new. Health plans have been using big data for a long time,” Catherine MacLean, MD, PHD, from Hospital for Special Surgery, told Healio Rheumatology. “What is new in big data is that these sources of data are now becoming more available.”

Editorial

Big Data in Rheumatology: Is it a Cautionary Note?

Healio Rheumatology, July 2017
Leonard H. Calabrese, DO
Let me introduce this cautiously entitled Editorial by first expressing how pleased we are to have engaged such a talented and productive group of experts on the use of…

Novartis confirms 5-year efficacy for Cosentyx for psoriasis

July 18, 2017
Novartis has reported positive 5-year efficacy and safety results for Cosentyx from a phase 3 long-term extension study in patients with moderate-to-severe plaque…
Breaking News

FDA approves Tremfya for psoriasis

July 13, 2017
Janssen Biotech announced that the FDA has approved Tremfya for treating adults with moderate-to-severe psoriasis who are candidates for systemic therapy or…
CME

Psoriatic Arthritis

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with psoriatic arthritis.
More »
Video
Meeting News

VIDEO: Mease discusses effectiveness of tofacitinib against PsA

December 2, 2016
More »
Resource Centers
Biosimilars in the US

Biosimilars in the US

Advertisement
Advertisement